GENETIC-MAPPING OF THE CHARCOT-MARIE-TOOTH DISEASE TYPE-1 (CMT-1A) LOCUS

被引：0
|
作者：
VANCE, JM [1 ]
PERICAKVANCE, MA [1 ]
LUCAS, A [1 ]
STAJICH, J [1 ]
LENNON, F [1 ]
LOPREST, L [1 ]
YAMAOKA, LH [1 ]
ROSES, AD [1 ]
机构：
[1] DUKE UNIV,MED CTR,DURHAM,NC 27710
来源：
CYTOGENETICS AND CELL GENETICS | 1991年 / 58卷 / 3-4期
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：2010 / 2010
页数：1
相关论文
共 50 条
  • [31] IDENTIFICATION AND VALIDATION OF DISEASE MARKER IN CHARCOT-MARIE-TOOTH DISEASE 1A (CMT1A)
    Fledrich, R.
    Schlotter-Weigel, B.
    Schnizer, T.
    Stassart, R. M.
    Wichert, S.
    Hoerste, Meyer Zu G.
    Weiss, B. G.
    Haag, U.
    Walter, M. C.
    Rautenstrauss, B.
    Paulus, W.
    Nave, K-A
    Rossner, M. J.
    Sereda, M. W.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2011, 16 : S39 - S40
  • [32] Charcot-Marie-Tooth type 1A disease and therapy with ascorbic acid: The CMT-TRIAAL
    Pareyson, D.
    Schenone, A.
    Rizzuto, N.
    Fabrizi, G.
    Santoro, L.
    Vita, G.
    Quattrone, A.
    Padua, L.
    Gemignani, F.
    Visioli, F.
    Solari, A.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2007, 12 (02) : 166 - 167
  • [33] AUTOSOMAL-DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE-2 - INVESTIGATION OF GENETIC-HETEROGENEITY AND MAPPING OF THE CMT2A LOCUS
    VANCE, JM
    DENTON, VP
    OTHMANE, KB
    LENNON, F
    SLAJICH, JM
    DENG, H
    SIDDIQUE, T
    ROSES, AD
    PERICAKVANCE, MA
    NEUROLOGY, 1994, 44 (04) : A293 - A293
  • [34] Unilateral oculomotor palsy in Charcot-Marie-Tooth disease lA (CMT 1A)
    Posa, A.
    Emmer, A.
    Kornhuber, M. E.
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2017, 155 : 20 - 21
  • [35] Clinical and electrophysiological evaluation of 222 patients with Charcot-Marie-Tooth disease type 1A recruited in the CMT-TRIAAL (ascorbic acid therapy for Charcot-Marie-Tooth 1A disease)
    Pareyson, D.
    Schenone, A.
    Rizzuto, N.
    Fabrizi, G. M.
    Santoro, L.
    Vita, G.
    Quattrone, A.
    Padua, L.
    Gemignani, F.
    Visioli, F.
    Calabrese, D.
    Solari, A.
    JOURNAL OF NEUROLOGY, 2008, 255 : 104 - 105
  • [36] Unmasking a Case of Asymptomatic Charcot-Marie-Tooth Disease (CMT1A) With Vincristine
    Jariwal, Roopam
    Shoua, Basel
    Sabetian, Katayoun
    Natarajan, Piruthiviraj
    Cobos, Everardo
    JOURNAL OF INVESTIGATIVE MEDICINE HIGH IMPACT CASE REPORTS, 2018, 6
  • [37] Charcot-Marie-Tooth (CMT) Disease 1A with Superimposed Inflammatory Polyneuropathy in Children
    Desurkar, A.
    Lin, J. -P.
    Mills, K.
    Al-Sarraj, S.
    Jan, W.
    Jungbluth, H.
    Wraige, E.
    NEUROPEDIATRICS, 2009, 40 (02) : 85 - 88
  • [38] POSSIBLE HETEROGENEITY IN THE LINKAGE BETWEEN AUTOSOMAL DOMINANT CMT1 (CHARCOT-MARIE-TOOTH NEUROPATHY TYPE-1) AND FY
    MARAZITA, ML
    CEDERBAUM, SD
    SPENCE, MA
    CRANDALL, BF
    SPARKES, RS
    SPARKES, MC
    CRIST, M
    CYTOGENETICS AND CELL GENETICS, 1985, 40 (1-4): : 688 - 689
  • [39] Anticipation in Charcot-Marie-Tooth disease type 2 (CMT2)
    Vinci, P
    Oliveira, GR
    Antenor, JA
    Thomas, FP
    NEUROLOGY, 2001, 56 (08) : A324 - A325
  • [40] LINKAGE BETWEEN AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH NEUROPATHY TYPE-1 (CMT1) AND HUMAN GLUCOCEREBROSIDASE (GBA)
    IONASESCU, V
    GINNS, E
    BURNS, T
    SEARBY, C
    IONASESCU, R
    CYTOGENETICS AND CELL GENETICS, 1987, 46 (1-4): : 633 - 633
12345